Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NewLink Genetics Corp (NASDAQ:NLNK)

51.16
Delayed Data
As of 3:59pm ET
 -0.63 / -1.22%
Today’s Change
17.32
Today|||52-Week Range
58.73
+28.70%
Year-to-Date

Today’s Trading

Previous close51.79
Today’s open51.98
Day’s range49.82 - 51.98
Volume282,755
Average volume (3 months)587,006
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-151.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio13.3
Price/Sales7.15
Price/Book6.75

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...+0.07+0.67%
EGRXEagle Pharmaceutical...+2.08+2.20%
ACORAcorda Therapeutics ...+0.45+1.33%
ZSPHZS Pharma Inc+1.18+2.05%
Data as of 4:14pm ET, 07/30/2015

Financials

Next reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts